Pepcid ac and Diflucan drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Pepcid ac (famotidine) and Diflucan (fluconazole). Common drug interactions include gastroenteritis eosinophilic among females and blood potassium decreased among males.

The phase IV clinical study analyzes what interactions people have when they take Pepcid ac and Diflucan. It is created by eHealthMe based on reports of 58 people who take the same drugs from the FDA, and is updated regularly.

What is Pepcid ac?

Pepcid ac has active ingredients of famotidine. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 9,573 Pepcid ac users. Check the latest studies of Pepcid ac.

What is Diflucan?

Diflucan has active ingredients of fluconazole. It is often used in vaginal yeast infection. eHealthMe is studying from 28,471 Diflucan users. Check the latest studies of Diflucan.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 01, 2026

58 people who take Pepcid ac and Diflucan together, and have interactions are studied.

Pepcid ac and Diflucan drug interactions.

What are the common drug interactions of Pepcid Ac and Diflucan, by gender? *:

female:

  1. Gastroenteritis eosinophilic (white blood cell deposits in tissue of stomach or intestine with infection)
  2. Gastroenteritis viral (inflammation of stomach and intestine caused by virus infection)
  3. Haemoglobin decreased
  4. Hangover
  5. Hemiparesis (weakness on one side of the body)
  6. Hospitalisation
  7. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  8. Hypoglobulinaemia (deficiency of globulin in the bloodstream)
  9. Immunodeficiency
  10. Impaired gastric emptying

male:

  1. Blood potassium decreased
  2. Faecaloma (hard mass of fecal matter)
  3. Dyspnoea (difficult or laboured respiration)
  4. Fluid retention (an abnormal accumulation of fluid in the blood)
  5. Haemorrhage (bleeding)
  6. Hypersensitivity
  7. Injection site bruising
  8. Injection site haemorrhage (bleeding from injection site)
  9. Nephrogenic anaemia (anaemia due to kidney disease)
  10. Oedema peripheral (superficial swelling)

What are the common drug interactions of Pepcid Ac and Diflucan, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Chronic kidney disease
  2. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  3. Nephrogenic anaemia (anaemia due to kidney disease)
  4. Nephropathy (damage to or disease of a kidney)
  5. Renal failure (kidney dysfunction)
  6. Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)

30-39:

  1. Nephrogenic anaemia (anaemia due to kidney disease)
  2. Pulmonary hypertension (increase in blood pressure in the lung artery)
  3. Renal failure (kidney dysfunction)
  4. Renal failure acute (rapid kidney dysfunction)
  5. Right ventricular failure (right half of the heart fails to work)
  6. Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
  7. Diarrhoea
  8. Abdominal pain
  9. Anorexia (eating disorder characterized by immoderate food restriction and irrational fear of gaining weight)
  10. Anxiety

40-49:

  1. Chronic kidney disease
  2. Cystitis (inflammation of the wall of the bladder)
  3. Renal failure (kidney dysfunction)
  4. Kidney infection
  5. Mucosal inflammation (infection of mucous membrane)
  6. Catheter site cellulitis (infection of cells near catheter)
  7. Cellulitis (infection under the skin)
  8. Fatigue (feeling of tiredness)
  9. Implant site reaction
  10. Muscle spasms (muscle contraction)

50-59:

  1. Renal failure (kidney dysfunction)
  2. Chronic kidney disease
  3. Nephrogenic anaemia (anaemia due to kidney disease)
  4. Cardiac failure congestive
  5. Colitis microscopic (inflammation of colon with diarrhoea and abdominal cramps)
  6. Cystitis (inflammation of the wall of the bladder)
  7. Kidney infection
  8. Malaise (a feeling of general discomfort or uneasiness)
  9. Psoriasis (immune-mediated disease that affects the skin)
  10. Renal impairment (severely reduced kidney function)

60+:

  1. Dizziness
  2. Injection site haemorrhage (bleeding from injection site)
  3. Neutropenia (an abnormally low number of neutrophils)
  4. Renal failure (kidney dysfunction)
  5. Spider naevus (small dilated blood vessels near the surface of the skin)
  6. Spinal column stenosis (narrowing of spinal column)
  7. Abdominal discomfort
  8. Ascites (accumulation of fluid in the abdominal cavity)
  9. Asthenia (weakness)
  10. Bacteraemia (presence of bacteria in the blood)

What are the existing conditions these people have? *

  1. Pain: 19 people, 32.76%
  2. Hypersensitivity: 13 people, 22.41%
  3. Insomnia (sleeplessness): 12 people, 20.69%
  4. Infection: 12 people, 20.69%
  5. High Blood Cholesterol: 10 people, 17.24%
  6. Headache (pain in head): 9 people, 15.52%
  7. Stress And Anxiety: 8 people, 13.79%
  8. High Blood Pressure: 8 people, 13.79%
  9. Diabetes: 8 people, 13.79%
  10. Depression: 7 people, 12.07%

* Approximation only. Some reports may have incomplete information.

Do you take Pepcid ac and Diflucan?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Pepcid ac and Diflucan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Pepcid ac:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Diflucan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Pepcid ac and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Diflucan and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on famotidine and fluconazole (the active ingredients of Pepcid ac and Diflucan, respectively), and Pepcid ac and Diflucan (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: